The people behind SRTD Biotech

The people behind SRTD biotech

Our core team to cover what this platform demands: RNA biology, delivery science, computational discovery, drug development and business execution.

Management

Image of Matthias Alder, Chief Executive Officer of SRTD Biotech
Matthias Alder

Chief Executive Officer


Image of Dr. Bernd Hoffmann, Chief Scientific Officer and Found of SRTD Biotech
Dr. Bernd Hoffmann

Chief Scientific Officer and Founder


Leads SRTD through its transition from platform research to clinical development.

Thirty years as a biotech executive in the US and Europe, with prior roles at Autolus, GAIN Therapeutics, Cytos, Sucampo, Micromet and Novartis.

Inventor of the seRNA construct and of the fusogenic LNP delivery platform.

Group leader at Forschungszentrum Jülich, author of more than 100 publications, various patents and founder of three companies.

Image of Prof. Dr. Heinz Koeppl, Chief Technology Officer of SRTD Biotech
Prof. Dr. Heinz Koeppl

Chief Technology Officer


Image of Dr. Jens Hennecke, Chief Business Officer of SRTD Biotech
Dr. Jens Hennecke

Chief Business Officer


Runs target discovery and AI-driven seRNA optimization.

Professor at TU Darmstadt working on bioinformatics and AI, with more than 170 publications and five patents.

Leads partnering and corporate development.

Managing Director of HBCD Advisors, previously in biotech executive roles at SOTIO and Micromet, and board roles at NBE Therapeutics, Cytune Pharma and Athebio.

Advisory board members

Kristin Thompson

Merieux Equity Partners

Marek Kozlowski

NRW Ventures

Angelika Vlachou

High-Tech Gründerfonds Management GmbH

John Park

Boehringer Ingelheim Venture Funds

Matthias Alder

CEO, SRTD Biotech